Biotech · Private company
Priovant Therapeutics, Inc.
Track this companyFree. Adds Priovant Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials63 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- BrepocitinibPhase 3 · DermatomyositisClinicalTrials.gov · fetched Nov 12, 2026
- Brepocitinib PO QDPhase 3 · Uveitis, PosteriorClinicalTrials.gov · fetched Nov 12, 2026
- Oral BrepocitinibPhase 3 · Cutaneous SarcoidosisClinicalTrials.gov · fetched Nov 12, 2026
- Oral BrepocitinibPhase 3 · Lichen PlanopilarisClinicalTrials.gov · fetched Nov 12, 2026
- BrepocitinibPhase 2 · Non-infectious Intermediate UveitisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- A Phase 2/3 Study of Brepocitinib in Adults With Lichen PlanopilarisPHASE2_PHASE3 · RECRUITING · started Mar 19, 2026ClinicalTrials.gov NCT07532603 · fetched Nov 12, 2026
- A Study of Brepocitinib in Adults With Cutaneous SarcoidosisPHASE2_PHASE3 · RECRUITING · started Apr 9, 2025ClinicalTrials.gov NCT06978725 · fetched Nov 12, 2026
- A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior UveitisPHASE3 · ACTIVE_NOT_RECRUITING · started Sep 11, 2024ClinicalTrials.gov NCT06431373 · fetched Nov 12, 2026
- A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant DermatomyositisPHASE2 · COMPLETED · started Aug 28, 2024ClinicalTrials.gov NCT06433999 · fetched Nov 12, 2026
- A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior UveitisPHASE2 · COMPLETED · started Nov 14, 2022ClinicalTrials.gov NCT05523765 · fetched Nov 12, 2026
- A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With DermatomyositisPHASE3 · COMPLETED · started Oct 31, 2022ClinicalTrials.gov NCT05437263 · fetched Nov 12, 2026